National HealthCare Corporation filed SEC Form 8-K: Other Events, Financial Statements and Exhibits

false 0001047335 0001047335 2025-05-08 2025-05-08

 

 

 

 

 

(Exact name of registrant as specified in its charter)

__________________________

 

 

 

Registrant’s telephone number, including area code: (615) 890-2020

 

(Former name or former address, if changed since last report)

__________________________________

 

 

☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))

☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Exchange Act:

 

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1988 or Rule 12b-2 of the Securities Exchange Act of 1934. Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial standards pursuant to Section 13(a) of the Exchange Act. ☐

 

 

ITEM 8.01.         OTHER EVENTS.

 

NHC issued a press release on May 8, 2025, announcing its quarterly common dividend. The entire press release is attached as Exhibit 99.1 and is incorporated by reference herein.

 

 

ITEM 9.01.         FINANCIAL STATEMENTS AND EXHIBITS.

 

(d)         Exhibits.

 

 

 

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

Date:         May 9, 2025